Noncardiac Vascular Toxicities of Vascular Endothelial Growth Factor Inhibitors in Advanced Cancer: A Review

SUMMARY. The introduction of molecularly targeted anticancer therapies has brought the promise of longer survival times for select patients with cancers previously considered untreatable. However, it has also brought new toxicities that require understanding and management, sometimes for long period...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Keefe, Dorothy, Bowen, Joanne, Gibson, Rachel, Tan, Thean, Okera, Meena, Stringer, Andrea
Formato: Artigo
Lenguaje:Inglês
Publicado: AlphaMed Press 2011
Materias:
Cancer Biology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228115/
https://ncbi.nlm.nih.gov/pubmed/21441297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0271
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares